Multiple Myeloma Research Review, Issue 68

In this issue:

Good correlation between spot urine protein/creatinine ratio and 24-hour urine protein
Simultaneous biomarker assessment may replace sequential confirmation of response
New iStopMM-based criteria for LC-MGUS reduces overdiagnosis
MIDAS: MRD-guided consolidation may help avoid transplant in some patients
IgRT is effective for hypogammaglobulinemia and severe infections
Is t(11;14) always a standard-risk cytogenetic abnormality?
BELLINI fails to demonstrate survival benefit with venetoclax combo in RRMM
IRAKLIA: On-body isatuximab injector non-inferior to intravenous administration
Promising preclinical results for a NSD2 inhibitor for t(4;14)+ myeloma
 

Please login below to download this issue (PDF)

Subscribe